Cencora (COR) Competitors $291.51 +1.62 (+0.56%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$290.00 -1.51 (-0.52%) As of 08/29/2025 06:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock COR vs. ELV, MCK, CAH, HSIC, OMI, DHR, CVS, LH, NTRA, and ICLRShould you be buying Cencora stock or one of its competitors? The main competitors of Cencora include Elevance Health (ELV), McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Owens & Minor (OMI), Danaher (DHR), CVS Health (CVS), Labcorp (LH), Natera (NTRA), and Icon (ICLR). These companies are all part of the "medical" sector. Cencora vs. Its Competitors Elevance Health McKesson Cardinal Health Henry Schein Owens & Minor Danaher CVS Health Labcorp Natera Icon Elevance Health (NYSE:ELV) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, risk, earnings, valuation and institutional ownership. Do analysts prefer ELV or COR? Elevance Health presently has a consensus target price of $413.81, suggesting a potential upside of 29.72%. Cencora has a consensus target price of $311.25, suggesting a potential upside of 6.77%. Given Elevance Health's higher possible upside, research analysts plainly believe Elevance Health is more favorable than Cencora.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Elevance Health 0 Sell rating(s) 6 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.67Cencora 0 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.75 Which has better valuation & earnings, ELV or COR? Elevance Health has higher earnings, but lower revenue than Cencora. Elevance Health is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElevance Health$177.01B0.41$5.98B$23.5013.57Cencora$293.96B0.19$1.51B$9.7229.99 Which has more risk and volatility, ELV or COR? Elevance Health has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Is ELV or COR a better dividend stock? Elevance Health pays an annual dividend of $6.84 per share and has a dividend yield of 2.1%. Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.8%. Elevance Health pays out 29.1% of its earnings in the form of a dividend. Cencora pays out 22.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 14 consecutive years and Cencora has raised its dividend for 15 consecutive years. Do insiders & institutionals have more ownership in ELV or COR? 89.2% of Elevance Health shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 0.3% of Elevance Health shares are held by insiders. Comparatively, 10.8% of Cencora shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is ELV or COR more profitable? Elevance Health has a net margin of 2.83% compared to Cencora's net margin of 0.60%. Cencora's return on equity of 267.36% beat Elevance Health's return on equity.Company Net Margins Return on Equity Return on Assets Elevance Health2.83% 17.59% 6.36% Cencora 0.60%267.36%4.31% Does the media refer more to ELV or COR? In the previous week, Cencora had 11 more articles in the media than Elevance Health. MarketBeat recorded 40 mentions for Cencora and 29 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.54 beat Cencora's score of 1.23 indicating that Elevance Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 26 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Very Positive Cencora 25 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryElevance Health and Cencora tied by winning 9 of the 18 factors compared between the two stocks. Get Cencora News Delivered to You Automatically Sign up to receive the latest news and ratings for COR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding COR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COR vs. The Competition Export to ExcelMetricCencoraMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$56.54B$7.75B$5.72B$21.37BDividend Yield0.75%2.66%4.10%3.49%P/E Ratio29.9980.2683.2729.33Price / Sales0.1943.94536.9852.62Price / Cash14.6724.6337.4423.91Price / Book25.5720.9010.555.36Net Income$1.51B$242.04M$3.27B$996.52M7 Day Performance-0.25%-1.20%0.40%0.34%1 Month Performance1.90%5.22%7.31%5.52%1 Year Performance21.68%9.53%46.58%11.66% Cencora Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CORCencora4.5775 of 5 stars$291.51+0.6%$311.25+6.8%+21.7%$56.54B$293.96B29.9946,000Trending NewsAnalyst RevisionELVElevance Health4.8266 of 5 stars$316.31+2.2%$413.81+30.8%-42.7%$71.17B$177.01B13.45104,200Positive NewsMCKMcKesson4.3627 of 5 stars$672.790.0%$719.27+6.9%+22.3%$83.68B$359.05B26.8345,000Positive NewsAnalyst RevisionCAHCardinal Health4.9647 of 5 stars$149.17-0.3%$163.20+9.4%+31.8%$35.63B$222.58B23.1357,700Positive NewsHSICHenry Schein3.9223 of 5 stars$67.96+0.2%$75.58+11.2%-1.4%$8.25B$12.67B21.9425,000Trending NewsAnalyst UpgradeAnalyst RevisionOMIOwens & Minor4.7356 of 5 stars$5.53-2.6%$8.29+49.9%-68.4%$426.75M$10.70B-0.3523,200Analyst ForecastDHRDanaher4.9174 of 5 stars$210.920.0%$247.61+17.4%-23.5%$151.10B$23.88B44.9063,000Positive NewsCVSCVS Health4.9497 of 5 stars$70.38+2.6%$76.67+8.9%+27.8%$89.38B$372.81B19.69300,000Trending NewsAnalyst ForecastInsider TradeLHLabcorp4.823 of 5 stars$270.70+0.1%$289.58+7.0%+21.0%$22.50B$13.01B29.8970,000Positive NewsNTRANatera3.0468 of 5 stars$162.66-0.2%$193.19+18.8%+42.3%$22.34B$1.96B-85.234,434Positive NewsICLRIcon4.0856 of 5 stars$176.57+0.4%$219.54+24.3%-44.7%$14.25B$8.28B18.1641,900News CoveragePositive News Related Companies and Tools Related Companies ELV Competitors MCK Competitors CAH Competitors HSIC Competitors OMI Competitors DHR Competitors CVS Competitors LH Competitors NTRA Competitors ICLR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:COR) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cencora, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cencora With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free COR Stock Alerts